查詢結果分析
相關文獻
- 比較風險群組成本效益--以急性呼吸窘迫症候群(ARDS)為例
- 勞保被保險人腦血管疾病之疾病成本分析
- 臺灣地區藥物濫用社會成本推估初報
- First Successful Resuscitation of Mother and Delivery of Baby in a Patient with Severe H1N1 Complicated with ARDS in Taiwan: Experience with ECMO
- 製造業職災死亡之潛在人年損失分析
- 重大職業傷害所造成社會經濟成本之評估--以臺灣製造業為例
- 塗藥心臟血管支架之醫療費用結構與成本效益分析--與傳統支架之比較
- 氣候變遷對健康效益評估之概述
- 竹東及朴子兩地區肥胖直接成本之估計:疾病成本法
- 肥胖治療的成本與成本效果:簡易文獻回顧
頁籤選單縮合
題 名 | 比較風險群組成本效益--以急性呼吸窘迫症候群(ARDS)為例=Cost-Effectiveness Comparison of Risk Groups: A Case Study Involving Acute Respiratory Distress Syndrome (ARDS) |
---|---|
作 者 | 任立中; 李淑玉; 高國晉; | 書刊名 | 臺灣公共衛生雜誌 |
卷 期 | 33:4 2014.08[民103.08] |
頁 次 | 頁445-453 |
分類號 | 419.45 |
關鍵詞 | 急性呼吸窘迫症侯群; 疾病成本; 增加成本效益比; 人力資本法; Acute respiratory distress syndrome; ARDS; Cost of illness; Incremental cost-effectiveness ratio; ICER; Human capital approach; |
語 文 | 中文(Chinese) |
中文摘要 | 目標:本研究針對存活機率風險群組進行疾病成本探究,期望提供未來醫療政策及相關研究參考。方法:採回溯性病歷研究藉由研究變項建立預測存活機率風險群組,進而審視各群組未來健保署及增加一個生活品質調整後存活人年(1QALY)所需的醫療資源。結果:直接成本占全民健保醫療保健支出住院給付0.087%,在個人醫療保健支出則高出10倍,間接成本(中位數)占人均GDP12%,每增加一位高風險、中風險、低風險患者,健保署則需支付874,104元、1,420,035元、3,488,272元,而健保DRGs相對權重無法呈現資源耗用程度差異性。結論:整體而言,醫療資源耗用影響與DRGs健保支付制度應考慮診斷碼正確性與疾病嚴重度、共病症概念,而從醫療經濟決策點本研究樣本群組均達世界衛生組織建議成本效益評估標準,亦符合成本效果閾值的經濟性,提供未來研擬成本投入與效用措施評估的參考依據。 |
英文摘要 | Objectives: This study explored the healthcare costs of various risk groups based on survival probability. Our findings can serve as a reference for healthcare policymakers and researchers. Methods: Using a retrospective study of patient records, we identified variables to forecast the probability of survival in risk groups in an effort to analyze the resources required from the National Health Insurance (NHI) Administration to add one quality-adjusted life year (1QALY) to each group. Results: Direct costs were shown to account for 0.087% of NHI expenditures on hospital care subsidies, and increased 10-fold when reimbursed by private health insurance. Indirect costs (median) were shown to account for GDP12% per capita. Each additional high-, moderate, or low-risk patient cost the NHI Administration NTD 874,104, NTD 1,420,035 and NTD 3,488,272, respectively. Notably, the relative weights of diagnosis-related groups (DRGs) did not exhibit any differences in the level of resource consumption. Conclusions: Important issues to consider in the consumption of medical resources and NHI spending on DRGs include the accuracy of diagnostic coding, the severity of illnesses, and co-morbidities. From an economic healthcare perspective, the sample groups in this study all met the evaluation criteria for cost-effectiveness recommended by the World Health Organization, and surpassed the economic threshold for cost-effectiveness. Our results can serve as a reference for future assessment of cost input and usage effectiveness. |
本系統中英文摘要資訊取自各篇刊載內容。